De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Analabs Resources Berhad Toekomstige groei

Future criteriumcontroles 0/6

Momenteel beschikken we niet over voldoende analisten om de groei en omzet voor Analabs Resources Berhad te voorspellen.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Chemicals winstgroei	18.4%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	None
Laatst bijgewerkt	n/a

Recente toekomstige groei-updates

Geen updates

Recent updates

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Jan 04

Analabs Resources Berhad (KLSE:ANALABS) Is Due To Pay A Dividend Of MYR0.02

Feb 13

Analabs Resources Berhad (KLSE:ANALABS) Is Doing The Right Things To Multiply Its Share Price

Mar 28

Analabs Resources Berhad (KLSE:ANALABS) Has A Pretty Healthy Balance Sheet

Jan 21

Here's Why Analabs Resources Berhad (KLSE:ANALABS) Can Manage Its Debt Responsibly

Sep 13

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

May 24

Analabs Resources Berhad (KLSE:ANALABS) Might Be Having Difficulty Using Its Capital Effectively

Apr 28

Here's Why We Think Analabs Resources Berhad (KLSE:ANALABS) Is Well Worth Watching

Apr 07

Could Analabs Resources Berhad (KLSE:ANALABS) Have The Makings Of Another Dividend Aristocrat?

Mar 17

Should You Buy Analabs Resources Berhad (KLSE:ANALABS) For Its Upcoming Dividend?

Feb 19

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Analabs Resources Berhad onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

KLSE:ANALABS - Toekomstschattingen van analisten en financiële gegevens uit het verleden (MYR Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
7/31/2024	146	29	22	23	N/A
4/30/2024	152	28	24	24	N/A
1/31/2024	158	35	28	30	N/A
10/31/2023	154	33	26	27	N/A
7/31/2023	145	31	22	23	N/A
4/30/2023	133	28	15	16	N/A
1/31/2023	125	12	19	19	N/A
10/31/2022	123	21	12	14	N/A
7/31/2022	116	23	13	15	N/A
4/30/2022	116	29	15	17	N/A
1/31/2022	120	29	4	6	N/A
10/31/2021	119	24	11	11	N/A
7/31/2021	117	19	10	11	N/A
4/30/2021	117	16	11	11	N/A
1/31/2021	108	13	13	13	N/A
10/31/2020	105	9	16	17	N/A
7/31/2020	109	9	19	20	N/A
4/30/2020	111	7	20	21	N/A
1/31/2020	109	5	18	18	N/A
10/31/2019	112	5	16	22	N/A
7/31/2019	122	5	8	14	N/A
4/30/2019	130	4	4	10	N/A
1/31/2019	136	8	-6	5	N/A
10/31/2018	142	10	-3	2	N/A
7/31/2018	136	9	2	7	N/A
4/30/2018	138	9	N/A	9	N/A
1/31/2018	145	9	N/A	19	N/A
10/31/2017	144	9	N/A	22	N/A
7/31/2017	148	11	N/A	28	N/A
4/30/2017	150	11	N/A	23	N/A
1/31/2017	158	12	N/A	20	N/A
10/31/2016	155	13	N/A	19	N/A
7/31/2016	158	14	N/A	22	N/A
4/30/2016	155	13	N/A	28	N/A
1/31/2016	151	12	N/A	24	N/A
10/31/2015	153	9	N/A	21	N/A
7/31/2015	143	7	N/A	15	N/A
4/30/2015	142	7	N/A	18	N/A
1/31/2015	135	6	N/A	22	N/A
10/31/2014	136	8	N/A	21	N/A
7/31/2014	140	8	N/A	21	N/A
4/30/2014	140	10	N/A	20	N/A
1/31/2014	146	11	N/A	13	N/A
10/31/2013	146	11	N/A	11	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van ANALABS boven de spaarquote ( 3.6% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van ANALABS naar verwachting sneller zal groeien dan de markt MY

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van ANALABS naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van ANALABS naar verwachting sneller zal groeien dan de markt MY.

Hoge groei-inkomsten: Er zijn onvoldoende gegevens om te bepalen of de omzet van ANALABS naar verwachting sneller zal groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van ANALABS naar verwachting over 3 jaar hoog zal zijn

Analabs Resources Berhad Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

First quarter 2025 earnings released: EPS: RM0.051 (vs RM0.036 in 1Q 2024)

Analabs Resources Berhad, Annual General Meeting, Oct 10, 2024

Full year 2024 earnings released: EPS: RM0.25 (vs RM0.21 in FY 2023)

Third quarter 2024 earnings released: EPS: RM0.026 (vs RM0.012 in 3Q 2023)

Analabs Resources Berhad Appoints Ling Hua Kang as Independent and Non Executive Member of Remuneration Committee

Upcoming dividend of RM0.021 per share

Analabs Resources Berhad Declares an Single Tier Interim Dividend for the Financial Year Ending 30 April 2024, Payable on 22 March 2024

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

New major risk - Financial position

Analabs Resources Berhad Reports Write Offs for the Quarter Ended October 31, 2023

Analabs Resources Berhad Declares Interim Dividend for the Financial Year Ending 30 April 2024

Analabs Resources Berhad Appoints Mr. Ling Hua Kang as Independent and Non Executive Independent Director

Full year 2023 earnings released: EPS: RM0.21 (vs RM0.27 in FY 2022)

Analabs Resources Berhad, Annual General Meeting, Oct 04, 2023

Full year 2023 earnings released: EPS: RM0.21 (vs RM0.27 in FY 2022)

Third quarter 2023 earnings released: EPS: RM0.012 (vs RM0.098 in 3Q 2022)

Upcoming dividend of RM0.02 per share at 1.4% yield

Analabs Resources Berhad (KLSE:ANALABS) Is Due To Pay A Dividend Of MYR0.02

Analabs Resources Berhad Declares Interim Dividend for the Financial Year Ending 30 April 2023, Payable on 10 March 2023

Second quarter 2023 earnings released: EPS: RM0.051 (vs RM0.063 in 2Q 2022)

Analabs Resources Berhad Declares Single Tier Interim Dividend for the Financial Year Ending 30 April 2023

Analabs Resources Berhad Announces Cessation of Office of Mr. Lai Yew Choong as Independent and Non Executive Member of Risk Committee

Insufficient new directors

Analabs Resources Berhad, Annual General Meeting, Oct 05, 2022

Analabs Resources Berhad Appoints Chia Yee Yan as Independent and Non Executive Member of Audit Committee

Full year 2022 earnings released: EPS: RM0.27 (vs RM0.15 in FY 2021)

Analabs Resources Berhad Appoints Chia Yee Yan as Independent and Non Executive Director

Analabs Resources Berhad Re-Designates Kan Mun Hoow as Chief Executive Officer, Effective from 1 April 2022

Analabs Resources Berhad (KLSE:ANALABS) Is Doing The Right Things To Multiply Its Share Price

Third quarter 2022 earnings released: EPS: RM0.098 (vs RM0.051 in 3Q 2021)

Upcoming dividend of RM0.02 per share

Analabs Resources Berhad Announces Single-Tier Interim Dividend for the Period Ending April 30, 2022, Payable on March 11, 2022

Analabs Resources Berhad (KLSE:ANALABS) Has A Pretty Healthy Balance Sheet

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Here's Why Analabs Resources Berhad (KLSE:ANALABS) Can Manage Its Debt Responsibly

Full year 2021 earnings released: EPS RM0.15 (vs RM0.067 in FY 2020)

Full year 2021 earnings released

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Analabs Resources Berhad (KLSE:ANALABS) Might Be Having Difficulty Using Its Capital Effectively

Here's Why We Think Analabs Resources Berhad (KLSE:ANALABS) Is Well Worth Watching

Third quarter 2021 earnings released: EPS RM0.051 (vs RM0.012 in 3Q 2020)

Could Analabs Resources Berhad (KLSE:ANALABS) Have The Makings Of Another Dividend Aristocrat?

New 90-day low: RM1.10

Should You Buy Analabs Resources Berhad (KLSE:ANALABS) For Its Upcoming Dividend?

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

New 90-day high: RM1.19

Is Analabs Resources Berhad (KLSE:ANALABS) Set To Make A Turnaround?

Second quarter 2021 earnings released: EPS RM0.022

Is Analabs Resources Berhad (KLSE:ANALABS) An Attractive Dividend Stock?

New 90-day high: RM1.22

Analabs Resources Berhad Announces the Resignation of TAN AI PENG as Company Secretary

First quarter earnings released

Full year earnings released - EPS RM0.067

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven